Adaptive and innovative Radiation Treatment FOR improving Cancer treatment outcomE (ARTFORCE); a randomized controlled phase II trial for individualized treatment of head and neck cancer

Jolien Heukelom, Olga Hamming, Harry Bartelink, Frank Hoebers, Jordi Giralt, Teresa Herlestam, Marcel Verheij, Michiel van den Brekel, Wouter Vogel, Nick Slevin, Eric Deutsch, Jan-Jakob Sonke, Philippe Lambin, Coen Rasch

Research output: Contribution to journalArticleAcademicpeer-review

35 Citations (Scopus)
Original languageEnglish
Article number84
JournalBMC Cancer
Volume13
DOIs
Publication statusPublished - 22 Feb 2013

Keywords

  • Head and neck
  • Squamous cell carcinoma
  • Adaptive radiotherapy
  • Dose painting
  • Zirconium
  • Cetuximab
  • Cisplatin

Cite this

Heukelom, J., Hamming, O., Bartelink, H., Hoebers, F., Giralt, J., Herlestam, T., Verheij, M., van den Brekel, M., Vogel, W., Slevin, N., Deutsch, E., Sonke, J-J., Lambin, P., & Rasch, C. (2013). Adaptive and innovative Radiation Treatment FOR improving Cancer treatment outcomE (ARTFORCE); a randomized controlled phase II trial for individualized treatment of head and neck cancer. BMC Cancer, 13, [84]. https://doi.org/10.1186/1471-2407-13-84